Longeveron (LGVN) Other Non Operating Income (2020 - 2026)
Longeveron's Other Non Operating Income was $98,000 in Q2 2026, down 73.4% from $369,000 a year earlier but up 151.3% from the prior quarter.
Longeveron (LGVN) Other Non Operating Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Longeveron's Other Non Operating Income was $278,000 through Jun 30, 2026, down 71.3% year-over-year; for FY2025, it came in at $680,000, up 23.9% from FY2024.
- Other Non Operating Income shows a five-year compound annual growth rate of 64.2% (FY2020 to FY2025).
- In earlier years, Other Non Operating Income was $549,000 in FY2024, -$377,000 in FY2023, $300,000 in FY2022 (-27.0%) and $411,000 in FY2021 (+621.1%).
- Quarterly Other Non Operating Income has moved between -$1.4 million (Q2 2022) and $1.88 million (Q4 2022) over five years.
- Compared with a year earlier, Other Non Operating Income has declined for four straight quarters, with growth averaging 112.5% over the last seven quarters.
- The best year-over-year quarter for Other Non Operating Income over five years was Q1 2025 (growth of 431.3%); the worst was Q1 2026 (a decline of 77.1%).
- Per Business Quant data, LGVN's Other Non Operating Income in the three quarters before Q2 2026 was $39,000 (Q1 2026), $52,000 (Q4 2025) and $89,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Longeveron | 7.81 Mn | -32.00 Mn | 182,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98,000.00 |
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 369,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | -581,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | -116,000.00 |
| Dec 31, 2021 | -37,000.00 |
| Sep 30, 2021 | 50,000.00 |
Longeveron Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LGVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();